Pitiriasis Rubra Pilaris yang Berhubungan dengan HIV

Penulis

  • Rudi Chandra Fakultas Kedokteran Universitas Prima Indonesia
  • Abdul Arif Medan, Indonesia
  • Cayadi S Antonius Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v47i6.629

Kata Kunci:

pitiriasis rubra pilaris, HIV

Abstrak

Pitiriasis rubra pilaris (PRP) merupakan dermatosis papuloskuamosa idiopatik yang tidak diketahui penyebabnya, ditandai dengan papul-papul folikular hiperkeratotik berkoalesen menjadi plak bersisik jingga-kemerahan, islands of sparing, dan keratoderma palmoplantar. PRP awalnya diklasifikasikan oleh Griffiths ke dalam 5 kelompok berdasarkan gambaran klinis, onset usia, dan prognosis. Kemudian oleh Miralles, et al, diusulkan kelompok ke-6 yang berhubungan dengan human immunodeficiency virus (HIV). Insidens PRP berkisar dari 1 dari 5.000 di Inggris sampai 1 dari 50.000 di India, puncaknya pada dekade pertama dan kelima. Diagnosis PRP melalui manifestasi klinis dan pemeriksaan histopatologi. Pilihan pengobatan PRP tipe VI berbeda dengan tipe lainnya.

 

Pityriasis rubra pilaris (PRP) is an idiopathic papulosquamous dermatosis with unknown etiology; characterized by hyperkeratotic follicular papules which coalesce into reddish-orange scaly plaques, islands of sparing, and palmoplantar keratoderma. PRP was initially classified by Griffiths into 5 groups based on clinical features, age of onset, and prognosis. Miralles et al. proposed the 6th group related to human immunodeficiency virus (HIV). The incidence of PRP ranges from 1 in 5.000 in the UK to 1 in 50.000 in India, with peaks in the first and fifth decades. Diagnosis can be established through clinical manifestations and histopathological examination. Treatment options for PRP type VI are different from other types.

Unduhan

Data unduhan belum tersedia.

Referensi

Ifeanyi EO, Angela OG, Ifeanyi OC, Anne EN, Madu NH. HIV-associated pityriasis rubra pilaris in a 15-year-old girl. Trop J Med Res. 2015;18:124-6.

Wang D, Chong VCL, Chong WS, Oon HH. A review on pityriasis rubra pilaris. Am J Clin Dermatol, 2018;19:377–90. https://doi.org/10.1007/s40257-017-0338-1

Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: A review of diagnosis and treatment. Am J Clin Dermatol, 2010;11(3):157-70. Doi:1175-0561/10/0003-0157/$49.95/0

Pincus DJ. Pityriasis rubra pilaris: A clinical review. Dermatol Nursing, 2005;17(6): 448-51.

Bruch-Gerharz D, Ruzicka T. Pityriasis rubra pilaris. In: Wolf K, Goldsmith LA, Katz SI, Gilchrest BA, PallerAS, Leffel DJ, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York. McGrawHill: 2012. p. 279-84.

Finzi AF, Altomare G, Bergamaschini L, Tucci A. Pityriasis rubra pilaris and retinol-binding protein. Br J Dermatol. 1981;104:253–6.

Sehgal VN, Srivastava G, Dogra S. Adult onset pityriasis rubra pilaris. Indian J Dermatol Venereol Leprol, 2008;74(4):311-21.

Fung YP. Pityriasis rubra pilaris: An update review. HK Dermatol Venereol Bull. 2001;9:10-6.

De D, Dogra S, Narang T, Radotra BD, Kanwar AJ. Pityriasis rubra pilaris in a HIV-positive patient (Type 6 PRP). Skinmed, 2008;7(1):47-50.

Nair PA, Sheth N. Atypical adult-onset pityriasis rubra pilaris in an HIV-positive adult male. Indian J Dermatol, 2018;63(6):522-24. Doi: 10.4103/ijd.IJD_141_18.

Gonzalez-Lopez A, Velasco E, Pozo T, Del Villar A. HIV-associated pityriasis rubra pilaris responsive to triple antiretroviral therapy. Br J Dermatol, 1999;140:931–4.

Lerebours-Nadal L, Beck-Sague CM, Parker D, Gosman A, Saavedra A, Engel K, et al. Severe, disfiguring, pityriasis rubra pilaris in a woman in the Dominican Republic: Histopathologic diagnosis and response to antiretroviral therapy. J Int Assoc Provid AIDS Care. 2016;15:11–4.

Diterbitkan

2020-08-03

Cara Mengutip

Chandra, R., Arif, A., & Antonius, C. S. (2020). Pitiriasis Rubra Pilaris yang Berhubungan dengan HIV. Cermin Dunia Kedokteran, 47(6), 455–458. https://doi.org/10.55175/cdk.v47i6.629